Risk factors for recurrence of giant cell tumours of bone.
OBJECTIVE
To determine the risk factors for recurrence of giant cell tumours (GCTs) of bone.


METHODS
Medical records of 29 men and 29 women (mean age, 34 years) treated for primary (n=53) or recurrent (n=5) GCTs of bone and followed up for a mean of 40.2 months were reviewed. The tumours were located in the distal femur (n=18), proximal tibia (n=10), proximal femur (n=8), distal radius (n=7), proximal fibula (n=4), distal ulna (n=3), calcaneum (n=3), sacrum (n=2), vertebra (n=1), metatarsal (n=1), and distal humerus (n=1). 26 patients had pathological fractures, 12 had cortical break, and 20 had neither. The Campanacci grades of the tumours were I (n=1), II (n=18), and III (n=33); the grades of the remaining 6 tumours were unknown because radiographs were unavailable. The Enneking stages of the tumours were 1 (n=51), 2 (n=6), and 3 (n=1). Treatment included curettage and cementation (n=29), curettage, cementation, and adjuvant treatment with distilled water or liquid nitrogen for bones without fracture (n=18), wide resection for extensive soft tissue involvement (n=9), and amputation (n=2) for a recurrent GCT of the distal femur and a primary GCT of the calcaneus. Reconstruction included cementation (n=27), bone grafting (n=7), cementation/bone grafting with internal fixation (n=14), reconstruction with endoprosthesis (n=3), and none (n=7).


RESULTS
19 patients had recurrence after a mean of 23.1 months. The overall recurrence-free survival at years 1, 2, and 3 were 86%, 79%, and 72%, respectively. Recurrence did not correlate with patient age (p=0.20), primary or recurrent tumour at presentation (p=0.12), Campanacci grade (p=0.10), Enneking stage (p=0.54), or presence of pathological fracture (p=0.28). Compared to GCTs at other locations, GCTs in the proximal tibia were more likely to recur (27% vs. 60%, p=0.04).


CONCLUSIONS
GCTs of the proximal tibia are more likely to recur than those at other locations.
Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
Mashfiqul A
MA
Siddiqui
Chusheng
C
Seng
Mann Hong
MH
Tan
D000328:Adult; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D005269:Femur; D005360:Fibula; D005500:Follow-Up Studies; D018212:Giant Cell Tumor of Bone / Q000175:diagnosis* / Q000601:surgery; D006801:Humans; D006811:Humerus; D015994:Incidence; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D011884:Radius; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012846:Singapore / Q000453:epidemiology; D015996:Survival Rate / Q000639:trends; D013977:Tibia; D013997:Time Factors
giant cell tumor of bone; neoplasm recurrence, local